Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02160821
Other study ID # 1610841001
Secondary ID
Status Completed
Phase Phase 4
First received May 29, 2014
Last updated June 9, 2014
Start date January 2011
Est. completion date May 2014

Study information

Verified date June 2014
Source Nemours Children's Clinic
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Transversus abdominis plane block (TAPB) has emerged as a safe and effective regional anesthesia technique for providing postoperative lower abdominal analgesia. Complications associated with TAPB are very rare and pose a lower overall risk to the patient receiving a TAPB versus a caudal block, which is considered the gold standard for pediatric lower abdominal regional anesthesia. Our study hypothesis was that TAPB would be equivalent to caudal block initially in providing postoperative pain control but would show improved pain relief beyond the anticipated caudal duration.


Description:

The study design was a double-blinded randomized controlled trial. A minimum of 44 children between the ages of 1 and 9 undergoing bilateral ureteral reimplantation surgery through a low transverse incision will be enrolled. Narcotic requirement, pain scores (FLACC/FACES), episodes of nausea/vomiting, and anti-spasmodic requirement will be recorded in the PACU and at 6 hour intervals through 24 hours from the time of the block placement.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date May 2014
Est. primary completion date December 2013
Accepts healthy volunteers No
Gender Both
Age group 1 Year to 9 Years
Eligibility Inclusion Criteria:

- Patients aged 1 to 9 years old scheduled for intravesicular ureteral reimplantation surgery

Exclusion Criteria:

1. Coagulation status or anatomic variations precluded safe placement of either TAPB or caudal epidural,

2. there was a preexisting chronic pain disorder,

3. there was a history of constipation that persisted despite appropriate treatment and that may have impacted postoperative pain assessments,

4. additional procedures were planned via a separate incision at the time of the ureteral reimplantation, 5) there was a contraindication to receiving the medications described in the protocol.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Procedure:
Caudal Epidural
Ultrasound Guided Caudal Block
Transversus Abdominis Plane Block
Ultrasound Guided Transversus Abdominis Plane Block

Locations

Country Name City State
United States Wolfson Children's Hospital, Baptist Medical Center- Downtown, 800 Prudential Drive Jacksonville Florida

Sponsors (1)

Lead Sponsor Collaborator
Nemours Children's Clinic

Country where clinical trial is conducted

United States, 

References & Publications (2)

Tripi PA, Palmer JS, Thomas S, Elder JS. Clonidine increases duration of bupivacaine caudal analgesia for ureteroneocystostomy: a double-blind prospective trial. J Urol. 2005 Sep;174(3):1081-3. — View Citation

Vetter TR, Carvallo D, Johnson JL, Mazurek MS, Presson RG Jr. A comparison of single-dose caudal clonidine, morphine, or hydromorphone combined with ropivacaine in pediatric patients undergoing ureteral reimplantation. Anesth Analg. 2007 Jun;104(6):1356-63, table of contents. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Narcotic requirement Narcotic requirement was recorded at 24 hours from the time of the block placement. 24 hours post intervention No
Secondary episodes of nausea/vomiting Episodes of nausea/vomiting were recorded at 24 hours from the time of the block placement. 24 hours No
Secondary anti-spasmodic requirement Anti-spasmodic requirement were recorded at 24 hours from the time of the block placement. 24 hours post intervention No
Secondary Pain Scores Pain scores (FLACC/FACES) were recorded at 24 hours from the time of the block placement 24 hours post intervention No